loadpatents
name:-0.030141830444336
name:-0.017107963562012
name:-0.003882884979248
Mousa; Shaker Patent Filings

Mousa; Shaker

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mousa; Shaker.The latest application filed is for "composition and method for dual targeting in treatment of neuroendocrine tumors".

Company Profile
3.18.32
  • Mousa; Shaker - Wynantskill NY
  • Mousa; Shaker - Wynantskil NY
  • Mousa; Shaker - Wyantskil NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Composition and method for dual targeting in treatment of neuroendocrine tumors
Grant 11,351,137 - Mousa , et al. June 7, 2
2022-06-07
Composition And Method For Dual Targeting In Treatment Of Neuroendocrine Tumors
App 20210299262 - Mousa; Shaker ;   et al.
2021-09-30
Composition and method for dual targeting in treatment of neuroendocrine tumors
Grant 11,077,082 - Mousa , et al. August 3, 2
2021-08-03
Composition And Method For Dual Targeting In Treatment Of Neuroendocrine Tumors
App 20190314314 - Mousa; Shaker ;   et al.
2019-10-17
Composition and method for dual targeting in treatment of neuroendocrine tumors
Grant 10,328,043 - Mousa , et al.
2019-06-25
Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
Grant 10,259,804 - Elshourbagy , et al.
2019-04-16
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
Grant 9,839,614 - Mousa , et al. December 12, 2
2017-12-12
Anti-endothelial Lipase Compounds And Methods Of Using The Same In The Treatment And/or Prevention Of Cardiovascular Diseases
App 20170305887 - ELSHOURBAGY; Nabil ;   et al.
2017-10-26
Novel Hemostatic Patch And Uses Thereof
App 20170189573 - RUBIN; Leo ;   et al.
2017-07-06
Novel Formulations And Methods
App 20170049710 - RUBIN; Leo ;   et al.
2017-02-23
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations And Uses Thereof
App 20160199309 - Mousa; Shaker ;   et al.
2016-07-14
Formulations comprising T3 nanoparticles
Grant 9,381,255 - Rubin , et al. July 5, 2
2016-07-05
Novel Hemostatic Patch And Uses Thereof
App 20160151532 - RUBIN; Leo ;   et al.
2016-06-02
Novel Formulations And Methods
App 20140328933 - Rubin; Leo ;   et al.
2014-11-06
Novel Hemostatic Patch And Uses Thereof
App 20140322341 - Rubin; Leo ;   et al.
2014-10-30
Polycationic Compounds And Uses Thereof
App 20140051762 - Mousa; Shaker ;   et al.
2014-02-20
Novel Formulations And Methods
App 20130337053 - RUBIN; Leo ;   et al.
2013-12-19
Methods For Treating Organs
App 20130338072 - RUBIN; Leo ;   et al.
2013-12-19
Novel Formulations
App 20130243868 - RUBIN; Leo ;   et al.
2013-09-19
Polycationic compounds and uses thereof
Grant 8,507,723 - Mousa , et al. August 13, 2
2013-08-13
Formulations
Grant 8,404,281 - Rubin , et al. March 26, 2
2013-03-26
Polycationic Compounds And Uses Thereof
App 20120322878 - Mousa; Shaker ;   et al.
2012-12-20
Polycationic compounds and uses thereof
Grant 8,232,428 - Mousa , et al. July 31, 2
2012-07-31
Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
Grant 8,142,992 - Sehgal , et al. March 27, 2
2012-03-27
Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin
Grant 8,129,104 - Sehgal , et al. March 6, 2
2012-03-06
Polycationic compounds and uses thereof
Grant 8,129,566 - Mousa , et al. March 6, 2
2012-03-06
Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
Grant 8,129,103 - Sehgal , et al. March 6, 2
2012-03-06
Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier
Grant 7,964,338 - Sehgal , et al. June 21, 2
2011-06-21
Novel Formulations
App 20110142947 - Rubin; Leo ;   et al.
2011-06-16
Polycationic Compounds And Uses Thereof
App 20110124664 - Mousa; Shaker ;   et al.
2011-05-26
Polycationic Compounds And Uses Thereof
App 20100298344 - Mousa; Shaker ;   et al.
2010-11-25
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
Grant 7,741,311 - Mousa , et al. June 22, 2
2010-06-22
Method for treating occlusive vascular diseases & wound healing
Grant 7,736,636 - Mousa , et al. June 15, 2
2010-06-15
Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis
App 20100080843 - Mousa; Shaker ;   et al.
2010-04-01
Composition for Preserving Platelets and Method of Using the Same
App 20090263781 - Sehgal; Lakshman R. ;   et al.
2009-10-22
Composition For Preserving Platelets And Method Of Using The Same
App 20090253115 - SEHGAL; Lakshman R. ;   et al.
2009-10-08
Composition For Preserving Platelets And Method Of Using The Same
App 20080233554 - Sehgal; Lakshman R. ;   et al.
2008-09-25
Composition for preserving platelets and method of using the same
App 20060177811 - Sehgal; Lakshman R. ;   et al.
2006-08-10
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
App 20060147415 - Mousa; Shaker ;   et al.
2006-07-06
Soluble JAM-1, 2, and 3 as diagnostic & prognostic markers in cardiovascular, vascular, and inflammatory disorders
App 20050186136 - Mousa, Shaker
2005-08-25
Method for treating occlusive vascular diseases & wound healing
App 20050069518 - Mousa, Shaker ;   et al.
2005-03-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed